1. Canada Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Biome Grow Inc.

Biome Grow Inc.

BIO.CN
Biome Grow Inc.CA flagCanadian Securities Exchange
0.01
CAD
- -
- -
562,087.00Market Cap
Biome Grow Inc.
BIO.CN
(Canadian Securities Exchange)

Recent

price

0.01

P/E

ratio

- -

div

yld

- -

ROIC.AI

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Revenue per Share
- -
-0.71
-4.22
-0.94
0.16
-0.09
-0.09
- -
- -
-0.1
-0.02
Basic EPS, GAAP
- -
-0.49
-4.24
-0.31
- -
-0.08
-0.03
-0.02
-0.02
-0.01
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
-0.73
-4.76
-4.81
-4.51
0.13
0.04
0.04
0.03
-0.06
-0.07
Book Value per Share
- -
0.03
0.79
-0.2
0.01
0.09
0.02
0.06
0.06
-0.04
-0.04
Tangible Book Value per Share
- -
1
1
1
1
102
111
112
112
112
112
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
-4
-1
- -
-9
-9
- -
- -
-11
-2
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
3
1
8
6
-4
-5
Working Capital
- -
- -
- -
- -
- -
- -
2
2
- -
- -
- -
LT Debt
- -
- -
1
- -
- -
15
7
7
6
-4
-5
Total Equity
- -
- -
- -
- -
57.29
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
-3.55
- -
- -
- -
- -
- -
-46.91
Return on Capital (%)
- -
- -
- -
- -
- -
- -
-111.85
-6.01
-3.54
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Mar'23
Jun'23
Sep'23
ST Debt
4
4
4
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
112
112
112
Market Capitalization
1
1
1

Working Capital

FRC

•

in mil. unless spec.
Mar'23
Jun'23
Sep'23
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
5
5
5
Payables & Accruals
1
1
1
ST Debt
4
4
4
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
30,767.49%
-168.78%
Free Cash Flow
- -
70,575.88%
-59.63%
Net Income, GAAP
- -
534.84%
7,680.6%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
0.15
-0.11
-0.04
- -
- -
2022
-0.04
-0.04
-0.01
- -
-0.1
2023
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
Similar Companies
Cannonau Corp. (CNNC)
Gufic Biosciences Limited (GUFICBIO.NS)
HLB Pharmaceutical Co., Ltd (047920.KQ)
Unichem Laboratories Limited (UNICHEMLAB.BO)
CBD of Denver, Inc. (CBDD)
Ind-Swift Limited (INDSWFTLTD.BO)
Business
Biome Grow Inc. (CSE:BIO) operates as a Canadian cannabis company focused on cultivating, producing, distributing, and marketing medical and recreational cannabis products through its subsidiaries; core offerings include licensed production of dried cannabis flower, extracts, and related derivatives from facilities in Nova Scotia via Highland Grow Inc., medical cannabis in Newfoundland and Labrador via The Back Home Medical Cannabis Corporation, cultivation in Ontario via Great Lakes Cannabis Company Inc. and P-209 Inc., craft cannabis extraction in Prince Edward Island via Red Sands Craft Cannabis Co., and virtual reality retail technology via Weed Virtual Retail Inc. The company targets domestic markets in Atlantic Canada and Ontario with supply agreements to provincial liquor corporations such as the Nova Scotia Liquor Corporation and Newfoundland and Labrador Liquor Corporation, alongside plans for CBD-infused products and international exports; it maintains five retail licenses in Newfoundland and pursues B2B distribution channels. Founded in 2013 and headquartered in Toronto, Ontario, Biome Grow emphasizes vertically integrated operations across more than 200,000 square feet of production and research space, including partnerships with St. Francis Xavier University for genetics and cultivation R&D. Recent developments encompass the 2020 divestiture of Highland Grow Inc. to MYM Nutraceuticals Inc. for approximately $12.9 million in cash and shares, making Biome MYM's largest shareholder while retaining operational flexibility; compliance with a preservation order in an ongoing credit facility dispute with MYM; and sustained focus on regional ecosystems amid no material revenue generation in recent periods, with interim financial statements reflecting net losses and minimal assets against elevated liabilities as of late 2023.